Angioimmunoblastic T-Cell Lymphoma / Nodal TFH-cell lymphoma · line 1 · CHOEP (cyclophosphamide + doxorubicin + vincristine + etoposide + prednisone), 6 cycles

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Line of therapy	1
Track	standard
Linked regimen	`REG-CHOEP`

ID	`IND-AITL-1L-CHOEP`
Type	Indication
Status	reviewed 2026-04-25 \| pending_clinical_signoff
Diseases	`DIS-AITL`
Sources	`SRC-NCCN-BCELL-2025`

Notes

STUB. AITL-specific extension of T-cell CHOEP with EBV/AIHA/hypogamma layered workup.

Used By

Algorithms

ALGO-AITL-1L - ALGO-AITL-1L